Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000131.xml
Synfacts 2007(12): 1229-1229
DOI: 10.1055/s-2007-991303
DOI: 10.1055/s-2007-991303
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York
Synthesis of Thapsigargin
S. P. Andrews, M. Ball, F. Wierschem, E. Cleator, S. Oliver, K. Högenauer, O. Simic, A. Antonello, U. Hünger, M. D. Smith, S. V. Ley*
Cambridge University, UK
Further Information
Publication History
Publication Date:
22 November 2007 (online)
Significance
Thapsigargin is a potent inhibitor of sarco/endoplasmic reticulum ATPase (SERCA). By altering cellular Ca2+ levels, it disrupts cell growth and function. Peptide conjugates of thapsigargin have potential for the treatment of prostate cancer. The Cambridge synthesis (42 steps, 0.61% overall yield), starting from (S)-carvone, features an early Favorskii ring contraction to generate the cyclopentane B.